US-listed companies
agilon health, inc.

agilon health, inc.AGL

Market cap

$1.6B

P/E ratio

Income statement Balance sheet Cash flow

	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023
Cash and cash equivalents	1,040	497	108
Restricted cash and equivalents	15	11	7
Cash and cash equivalents	1,040	497	108
Marketable securities	-	412	-
Restricted cash and equivalents	15	11	7
Receivables, net	293	498	942
Marketable securities	-	-	381
Prepaid Expense and Other Assets, Current	19	34	43
Receivables, net	293	498	942
Prepaid Expense and Other Assets, Current	19	34	43
Total current assets	1,367	1,451	1,480
Total current assets	1,367	1,451	1,480
Property and equipment, net	9	20	28
Cash and cash equivalents	1,040	497	108
Restricted cash and equivalents	15	11	7
Cash and cash equivalents	1,040	497	108
Marketable securities	-	412	-
Restricted cash and equivalents	15	11	7
Receivables, net	293	498	942
Marketable securities	-	-	381
Prepaid Expense and Other Assets, Current	19	34	43
Receivables, net	293	498	942
Prepaid Expense and Other Assets, Current	19	34	43
Total current assets	1,367	1,451	1,480
Total current assets	1,367	1,451	1,480
Intangible assets, net	55	68	64
Property and equipment, net	9	20	28
Goodwill	42	42	24
Intangible assets, net	55	68	64
Other assets	113	117	145
Goodwill	42	42	24
Total assets	1,586	1,697	1,741
Other assets	113	117	145
Total assets	1,586	1,697	1,741
Medical claims and related payables	239	347	738
Accounts payable and accrued expenses	113	183	233
Medical claims and related payables	239	347	738
Current portion of long-term debt	5	5	6
Accounts payable and accrued expenses	113	183	233
Current portion of long-term debt	5	5	6
Total current liabilities	357	535	977
Total current liabilities	357	535	977
Long-term debt, net of current portion	43	38	32
Medical claims and related payables	239	347	738
Accounts payable and accrued expenses	113	183	233
Medical claims and related payables	239	347	738
Current portion of long-term debt	5	5	6
Accounts payable and accrued expenses	113	183	233
Current portion of long-term debt	5	5	6
Total current liabilities	357	535	977
Total current liabilities	357	535	977
Other liabilities	94	83	70
Long-term debt, net of current portion	43	38	32
Total liabilities	495	657	1,080
Other liabilities	94	83	70
Common Stock, Value, Issued	4	4	4
Additional paid-in capital	2,046	2,107	1,987
Common Stock, Value, Issued	4	4	4
Accumulated deficit	-958	-1,064	-1,327
Additional paid-in capital	2,046	2,107	1,987
Accumulated other comprehensive income (loss)	-	-6	-2
Accumulated deficit	-958	-1,064	-1,327
Total agilon health, inc. stockholders' equity (deficit)	1,092	1,041	662
Accumulated other comprehensive income (loss)	-	-6	-2
Noncontrolling interests	-0	-1	-1
Total agilon health, inc. stockholders' equity (deficit)	1,092	1,041	662
Total stockholders’ equity (deficit)	1,092	1,041	661
Noncontrolling interests	-0	-1	-1
Total stockholders’ equity (deficit)	1,092	1,041	661
Total liabilities	495	657	1,080
Total liabilities and stockholders’ equity (deficit)	1,586	1,697	1,741
Common Stock, Value, Issued	4	4	4
Additional paid-in capital	2,046	2,107	1,987
Common Stock, Value, Issued	4	4	4
Accumulated deficit	-958	-1,064	-1,327
Additional paid-in capital	2,046	2,107	1,987
Accumulated other comprehensive income (loss)	-	-6	-2
Accumulated deficit	-958	-1,064	-1,327
Total agilon health, inc. stockholders' equity (deficit)	1,092	1,041	662
Accumulated other comprehensive income (loss)	-	-6	-2
Noncontrolling interests	-0	-1	-1
Total agilon health, inc. stockholders' equity (deficit)	1,092	1,041	662
Total stockholders’ equity (deficit)	1,092	1,041	661
Noncontrolling interests	-0	-1	-1
Total stockholders’ equity (deficit)	1,092	1,041	661
Total liabilities and stockholders’ equity (deficit)	1,586	1,697	1,741
Cash and cash equivalents	1,040	497	108
Restricted cash and equivalents	15	11	7
Cash and cash equivalents	1,040	497	108
Marketable securities	-	412	-
Restricted cash and equivalents	15	11	7
Receivables, net	293	498	942
Marketable securities	-	-	381
Prepaid Expense and Other Assets, Current	19	34	43
Receivables, net	293	498	942
Prepaid Expense and Other Assets, Current	19	34	43
Total current assets	1,367	1,451	1,480
Total current assets	1,367	1,451	1,480
Property and equipment, net	9	20	28
Cash and cash equivalents	1,040	497	108
Restricted cash and equivalents	15	11	7
Cash and cash equivalents	1,040	497	108
Marketable securities	-	412	-
Restricted cash and equivalents	15	11	7
Receivables, net	293	498	942
Marketable securities	-	-	381
Prepaid Expense and Other Assets, Current	19	34	43
Receivables, net	293	498	942
Prepaid Expense and Other Assets, Current	19	34	43
Total current assets	1,367	1,451	1,480
Total current assets	1,367	1,451	1,480
Intangible assets, net	55	68	64
Property and equipment, net	9	20	28
Goodwill	42	42	24
Intangible assets, net	55	68	64
Other assets	113	117	145
Goodwill	42	42	24
Total assets	1,586	1,697	1,741
Other assets	113	117	145
Total assets	1,586	1,697	1,741
Medical claims and related payables	239	347	738
Accounts payable and accrued expenses	113	183	233
Medical claims and related payables	239	347	738
Current portion of long-term debt	5	5	6
Accounts payable and accrued expenses	113	183	233
Current portion of long-term debt	5	5	6
Total current liabilities	357	535	977
Total current liabilities	357	535	977
Long-term debt, net of current portion	43	38	32
Medical claims and related payables	239	347	738
Accounts payable and accrued expenses	113	183	233
Medical claims and related payables	239	347	738
Current portion of long-term debt	5	5	6
Accounts payable and accrued expenses	113	183	233
Current portion of long-term debt	5	5	6
Total current liabilities	357	535	977
Total current liabilities	357	535	977
Other liabilities	94	83	70
Long-term debt, net of current portion	43	38	32
Total liabilities	495	657	1,080
Other liabilities	94	83	70
Common Stock, Value, Issued	4	4	4
Additional paid-in capital	2,046	2,107	1,987
Common Stock, Value, Issued	4	4	4
Accumulated deficit	-958	-1,064	-1,327
Additional paid-in capital	2,046	2,107	1,987
Accumulated other comprehensive income (loss)	-	-6	-2
Accumulated deficit	-958	-1,064	-1,327
Total agilon health, inc. stockholders' equity (deficit)	1,092	1,041	662
Accumulated other comprehensive income (loss)	-	-6	-2
Noncontrolling interests	-0	-1	-1
Total agilon health, inc. stockholders' equity (deficit)	1,092	1,041	662
Total stockholders’ equity (deficit)	1,092	1,041	661
Noncontrolling interests	-0	-1	-1
Total stockholders’ equity (deficit)	1,092	1,041	661
Total liabilities	495	657	1,080
Total liabilities and stockholders’ equity (deficit)	1,586	1,697	1,741
Common Stock, Value, Issued	4	4	4
Additional paid-in capital	2,046	2,107	1,987
Common Stock, Value, Issued	4	4	4
Accumulated deficit	-958	-1,064	-1,327
Additional paid-in capital	2,046	2,107	1,987
Accumulated other comprehensive income (loss)	-	-6	-2
Accumulated deficit	-958	-1,064	-1,327
Total agilon health, inc. stockholders' equity (deficit)	1,092	1,041	662
Accumulated other comprehensive income (loss)	-	-6	-2
Noncontrolling interests	-0	-1	-1
Total agilon health, inc. stockholders' equity (deficit)	1,092	1,041	662
Total stockholders’ equity (deficit)	1,092	1,041	661
Noncontrolling interests	-0	-1	-1
Total stockholders’ equity (deficit)	1,092	1,041	661
Total liabilities and stockholders’ equity (deficit)	1,586	1,697	1,741